SCHEMBL25980920

SCHEMBL25980920

Cc1ccc(N(Cc2ccc(C(=O)NOI)cc2)C(=O)N2CC(C)OC(C)C2)c(C)c1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.42
ALDH1A1 P00352 5/20 0.40
HPGD P15428 3/20 0.40
CYP2C19 P33261 2/20 0.40
NPC1 O15118 2/20 0.35
RAB9A P51151 2/20 0.35
NPSR1 Q6W5P4 2/20 0.35
KCNH2 Q12809 1/20 0.35
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
CYP1A2 P05177 2/20 0.35
CRHBP P24387 1/20 0.35
CRHR2 Q13324 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
HTT P42858 1/20 0.34
HDAC1 Q13547 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25980896 0.86 RAB9A (0.42) ALDH1A1HPGDNPC1RAB9AMEN1
SCHEMBL25980910 0.86 HDAC1 (0.43) L3MBTL1ALDH1A1HPGDCYP2C19NPC1
SCHEMBL25980807 0.82 L3MBTL1 (0.38) L3MBTL1ALDH1A1HPGDCYP2C19NPSR1
SCHEMBL16211946 0.80 STAT3 (0.44) L3MBTL1ALDH1A1HPGDCYP2C19HDAC1
SCHEMBL25979308 0.79 TSHR (0.41) L3MBTL1ALDH1A1HPGDNPSR1MEN1
SCHEMBL16211354 0.78 ALDH1A1 (0.42) L3MBTL1ALDH1A1HPGDCYP2C19NPSR1
SCHEMBL25980754 0.77 HDAC6 (0.48) ALDH1A1NPC1KMT2AHDAC1HDAC6
SCHEMBL25981731 0.76 ALDH1A1 (0.42) ALDH1A1HPGDKCNH2MEN1KMT2A
SCHEMBL16211810 0.75 STAT3 (0.44) HDAC1HDAC6
SCHEMBL25981153 0.74 CCR5 (0.41) L3MBTL1ALDH1A1HPGDKCNH2CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) CHONG KUN DANG PHARMACEUTICAL CORP. (KR) 2023-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230248735-A1 COMPOSITIONS FOR PREVENTING OR TREATING CHRONIC OBSTRUCTIVE PULMONARY DISEASES (COPD) NR1H2, CFTR, CYP11B2 L3MBTL1 4497/4885ALDH1A1 674/4885HPGD 14/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.